| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |